Summer, D., Garousi, J., Oroujeni, M., Mitran, B., Andersson, K. G., Vorobyeva, A., . . . Decristoforo, C. (2017). Cyclic versus Noncyclic Chelating Scaffold for (89)Zr-Labeled ZEGFR: 2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression. Mol Pharm.
Style de citation ChicagoSummer, Dominik, et al. "Cyclic Versus Noncyclic Chelating Scaffold for (89)Zr-Labeled ZEGFR: 2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression." Mol Pharm 2017.
Style de citation MLASummer, Dominik, et al. "Cyclic Versus Noncyclic Chelating Scaffold for (89)Zr-Labeled ZEGFR: 2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression." Mol Pharm 2017.
Attention : ces citations peuvent ne pas être correctes à 100%.